ML Image Analysis for Noninvasive Tumor Progression Estimation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for treating glioblastoma multiforme (GBM) are challenging due to variable cellular responses and rapid tumor growth, making it difficult to determine appropriate therapeutic strategies and predict tumor progression rates accurately.

Innovation Solution

A noninvasive data processing system using machine learning models analyzes tumor microenvironments and signaling pathways, specifically NF-κB activation, to estimate tumor growth rates based on fMRI scans and image data, incorporating features like cell shape and density, and utilizes models such as CNNs to predict disease progression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If machine learning models analyze tumor microenvironments and signaling pathways to estimate tumor growth rates, then measurement precision of disease progression is improved, but device complexity increases

Engineering Contradiction:
Improvetumor growth rate estimationVSAvoiddata processing system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments the complex analysis task into distinct components: image data processing, feature extraction (cell shape, density, signaling pathway activation), and machine learning model prediction. This modular approach enables precise tumor growth rate estimation while managing system complexity through structured data flow and specialized processing modules for each function.

Inventive Principle:
Principle #1Segmentation

2Ease of operation

If noninvasive methods using fMRI scans and image analysis are used to diagnose GBM, then ease of operation is improved, but measurement precision of tumor growth rate may worsen

Engineering Contradiction:
Improvenoninvasive diagnosisVSAvoidtumor growth rate estimation
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The system introduces machine learning models as intermediaries between noninvasive image data (fMRI scans, cell images) and tumor growth rate estimation. These models learn complex relationships from training data and translate visual features into quantitative growth rate predictions, enabling noninvasive diagnosis with improved measurement precision through pattern recognition in imaging data.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If therapeutic strategies are intensified to treat rapidly growing tumors, then productivity of treatment is improved, but object-affected harmful factors increase due to adverse side effects

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidadverse side effects
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The system implements feedback by continuously monitoring tumor growth rates through repeated noninvasive imaging and ML analysis. This enables dynamic adjustment of therapeutic intensity based on actual tumor response, allowing aggressive treatment when growth rates warrant it while reducing intensity when tumors respond well, thereby improving treatment productivity while minimizing unnecessary adverse side effects from overly intensive therapy.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12482564B2Data processing system for estimating disease progression rates
Publication Date: 2025.11.25 ADDANKI ANVITHA
  • US12482564B2 patent drawing
  • US12482564B2 patent drawing
  • US12482564B2 patent drawing

AI summary

A method for treatment of a disease by monitoring a progression of the disease includes obtaining image data including a representation of diseased cells of a patient. Based on the type of the disease, one or more features to extract from the image data are determined, the features each representing a physical parameter of at least one of the diseased cells represented in the image data. A feature vector is formed from the extracted features. A machine learning model is selected, and the feature vector is processed using the machine learning model. The machine learning model is trained with labeled image data representing instances of diseased cells having the disease and associating scores representing predicted rates of disease progression with the respective instances of diseased cells having the type of disease. Based on the processing, a score is determined that represents a predicted rate of disease progression indicated by the image data.